Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of personalized medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Mar 9, 2020

Jack Stover, CEO, Interpace Biosciences describes the changing landscape of drug development with the introduction of genetic data, creation of advanced diagnostic tests for pancreatic, thyroid, lung and esophageal cancers, and the resulting implications for treatment plans.  He also explains their work with big pharma...


Mar 9, 2020

Jack Stover, CEO, Interpace Biosciences describes the changing landscape of drug development with the introduction of genetic data, creation of advanced diagnostic tests for pancreatic, thyroid, lung and esophageal cancers, and the resulting implications for treatment plans.  He also explains their work with big pharma...


Mar 2, 2020

Dan Passeri, CEO, Cue Biopharma discusses their proprietary Immuno-STAT(TM) platform.  Cue Biopharma is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body to transform the treatment of cancer and autoimmune diseases.  The platform is designed to harness...


Mar 2, 2020

Dan Passeri, CEO, Cue Biopharma discusses their proprietary Immuno-STAT(TM) platform.  Cue Biopharma is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body to transform the treatment of cancer and autoimmune diseases.  The platform is designed to harness...


Feb 11, 2020

Ulf Jungnelius MD, CEO, Isofol Medical discusses the increasing incidence of colorectal cancer as a global issue and the current challenges in treating this devastating disease.  Dr. Jungnelius also talks about the company's drug candidate, arfolitixorin, currently being studied in a global Phase 3 clinical trial with...